Singapore, Singapore

Vikrant Arun Adsool

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Vikrant Arun Adsool: Innovator in Kinase Modulation

Introduction

Vikrant Arun Adsool is a prominent inventor based in Singapore, known for his significant contributions to the field of therapeutic compounds. With a total of 7 patents to his name, he has made remarkable strides in the development of innovative solutions for kinase-dependent diseases.

Latest Patents

Among his latest patents, Vikrant has focused on bicyclic compounds as kinase modulators. His work involves the development of derivatives of these compounds and their therapeutic applications. Specifically, his patents address the modulation of kinase enzymatic activity, which is crucial in treating various conditions, including cancer. Notably, his research emphasizes the potential of these compounds in combating hepatocellular carcinoma (HCC). The methods of synthesizing these compounds are also a key aspect of his recent disclosures.

Career Highlights

Vikrant Arun Adsool is affiliated with the Agency for Science, Technology and Research, where he continues to push the boundaries of scientific innovation. His expertise in the field has positioned him as a valuable asset in the research community, contributing to advancements in therapeutic strategies.

Collaborations

Vikrant has collaborated with notable colleagues, including Soo Yei Ho and Stephanie Eliane Blanchard, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Vikrant Arun Adsool's work in kinase modulation exemplifies the intersection of innovation and therapeutic development. His contributions are paving the way for new treatments in oncology, showcasing the importance of research in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…